S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:BNGO

Bionano Genomics Short Interest Ratio and Short Volume

$3.40
-0.31 (-8.36%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.34
$3.73
50-Day Range
$3.40
$6.12
52-Week Range
$0.49
$15.69
Volume
14.22 million shs
Average Volume
28.17 million shs
Market Capitalization
$983.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.85

Bionano Genomics (NASDAQ:BNGO) Short Interest Data

Current Short Volume
37,500,000 shares
Previous Short Volume
38,020,000 shares
Change Vs. Previous Month
-1.37%
Dollar Volume Sold Short
$187.50 million
Short Interest Ratio / Days to Cover
4.5
Last Record Date
November, 15 2021
Outstanding Shares
289,184,000 shares
Percentage of Shares Shorted
12.97%
Today's Trading Volume
14,224,600 shares
Average Trading Volume
28,170,047 shares
Today's Volume Vs. Average
-49.50%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Bionano Genomics ?

Sign up to receive the latest short interest report for Bionano Genomics and its competitors with MarketBeat's FREE newsletter.

Bionano Genomics (NASDAQ:BNGO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202137,500,000 shares $187.50 million -1.4%N/A4.5 $5.00
10/29/202138,020,000 shares $193.14 million -9.5%N/A4.7 $5.08
10/15/202142,030,000 shares $216.87 million +4.2%15.1%5.5 $5.16
9/30/202140,330,000 shares $221.82 million -9.4%14.5%4.9 $5.50
9/15/202144,490,000 shares $234.91 million -2.0%16.0%4.5 $5.28
8/31/202145,390,000 shares $264.62 million No Change16.3%4.2 $5.83
8/13/202145,390,000 shares $258.27 million +8.6%16.3%3.1 $5.69
7/30/202141,810,000 shares $247.93 million -6.9%15.0%2.3 $5.93
7/15/202144,920,000 shares $262.33 million -13.8%16.2%2.2 $5.84
6/30/202152,100,000 shares $381.89 million +36.2%18.8%2.2 $7.33
6/15/202138,260,000 shares $281.98 million -0.7%13.8%1.6 $7.37
5/28/202138,520,000 shares $237.67 million +5.4%13.9%1.6 $6.17
5/14/202136,550,000 shares $161.19 million +15.9%N/A1.4 $4.41
4/30/202131,530,000 shares $208.41 million +8.7%N/A1.1 $6.61
4/15/202129,020,000 shares $186.45 million +1.5%N/A0.8 $6.43
3/31/202128,580,000 shares $220.64 million +20.2%N/A0.6 $7.72
3/15/202123,780,000 shares $223.06 million +8.5%N/A0.3 $9.38
2/26/202121,920,000 shares $219.64 million +15.1%N/A0.3 $10.02
2/12/202119,050,000 shares $222.89 million -28.7%N/A0.2 $11.70
1/29/202126,700,000 shares $281.15 million +4.8%N/A0.3 $10.53
1/15/202125,470,000 shares $177.02 million +63.1%N/A0.4 $6.95
12/31/202015,620,000 shares $32.80 million +84.2%N/A0.3 $2.10
12/15/20208,480,000 shares $4.24 million +9.6%N/A1.3 $0.50
11/30/20207,740,000 shares $3.78 million +5.5%N/A1.5 $0.49
11/15/20207,340,000 shares $3.81 million +16.7%N/A1.3 $0.52

Institutional Investors Shorting Bionano Genomics (NASDAQ:BNGO)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Bionano Genomics. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
11/16/2021Jane Street Group LLC942,500286,400-69.6%$1.58 thousand
11/16/2021Citadel Advisors LLC917,700659,200-28.2%$3.63 thousand
11/12/2021Aristides Capital LLCN/A215,700N/A$1.19 thousand
11/12/2021Sculptor Capital LP305,300405,300+32.8%$2.23 thousand
11/12/2021Capital Fund Management S.A.N/A86,400N/A$475.00
11/12/2021Wolverine Trading LLC282,100182,500-35.3%$951.00
11/10/2021HAP Trading LLC32,80016,400-50.0%$18.00
10/28/2021Simplex Trading LLC285,000288,100+1.1%$1.96 thousand













Bionano Genomics (NASDAQ:BNGO) Short Interest Frequently Asked Questions

What is Bionano Genomics' current short interest?

Short interest is the volume of Bionano Genomics shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 37,500,000 shares of BNGO short. Learn More on Bionano Genomics' current short interest.

What is a good short interest ratio for Bionano Genomics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Bionano Genomics currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for Bionano Genomics

Which institutional investors are shorting Bionano Genomics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bionano Genomics: Jane Street Group LLC, Citadel Advisors LLC, Aristides Capital LLC, Sculptor Capital LP, Capital Fund Management S.A., Wolverine Trading LLC, HAP Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Bionano Genomics' short interest increasing or decreasing?

Bionano Genomics saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 37,500,000 shares, a decrease of 1.4% from the previous total of 38,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Bionano Genomics' short interest compare to its competitors?

0.00% of Bionano Genomics' shares are currently sold short. Here is how the short interest of companies in the industry of "analytical instruments" compare to Bionano Genomics: Cytek BioSciences, Inc. (0.92%), HORIBA, Ltd. (0.00%), Olink Holding AB (publ) (0.00%), Quanterix Co. (4.09%), Berkeley Lights, Inc. (12.26%), Singular Genomics Systems, Inc. (3.20%), Nautilus Biotechnology, Inc. (13.69%), EyePoint Pharmaceuticals, Inc. (4.23%), Rapid Micro Biosystems Inc (2.38%), and Akoya Biosciences, Inc. (2.49%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Bionano Genomics stock?

Short selling BNGO is an investing strategy that aims to generate trading profit from Bionano Genomics as its price is falling. Bionano Genomics' stock is trading down $0.31 today. To short Bionano Genomics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Bionano Genomics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bionano Genomics?

A short squeeze for Bionano Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNGO, which in turn drives the price of the stock up even further.

How often is Bionano Genomics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNGO, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.